Learn more about whether Recursion Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ ...
Fintel reports that on March 3, 2025, B of A Securities downgraded their outlook for Zai Lab Limited - Depositary Receipt () ...
Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s shares opened today at $35.16. See what stocks are ...
18d
Investor's Business Daily on MSNChina Biotech's Sales Jump 66% But Bottom Line Misses ViewsZai Lab pulled back after the biopharmaceutical reported fourth-quarter results. The biotech is building a cup base.
Learn more about whether Exact Sciences Corporation or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results